THE WHOLE DIABETES PACKAGE

As those of us with Diabetes(T1DM) already know, this Chronic Illness is more than a problem of metabolism. It is a "Package Deal". For no matter how well your blood sugars are controlled and your diet is optimized, the risk of complications related to T1DM are always there. Of course, this is only my opinion but having Diabetes(T1DM) since childhood and always educating myself about this Illness, I have come to the conclusion that the potential for complications of CHD(Coronary Heart Disease), Autonomic and Peripheral Neuropathy, Kidney Disease are always present and await for the "right opportunity" to make their presence known.
Fortunately there are those within the Medical and Science Communities who have created a number of impacts to starve off a number of these horrible "Side Effects" associated with long term Diabetes. They range from the ACE Inhibitors to protect our Kidneys to the Statins offering protection related to certain aspects of CHD. There has until now, been no way of protecting the body against the damage of Peripheral Neuropathy in Diabetes until now.
Thomas Brannagan, MD and his Staff are now in Phase ll Studies to evaluate the efficiency and Safety of a Research Medication in Patients with Mild to Moderate Diabetic Polyneuropathy.
Details of this study can be found in: The Journal Of Diabetes/3/2006 called "Orally Active Neurotrophin Enhancing Agent Protects Against Dysfunction Of Peripheral Nerve in Hyperglycemic Animals".
I have met with Dr. Brannagan and found him to have the qualities that we all wish/want every Physician that we encounter to have. They are intelligence, caring, ability to communicate and optimism for what they do. These are the qualities that describe Dr. Brannagan. Corinna on Staff w/Dr. Brannigan is both intelligent and efficient. She is responsible for the Research Medications, Study Protocol, Laboratory Tests, Appointments and "just making sure that everything operates smoothly". To reach Dr. Brannagan or Corinna here in NYC and enroll or ask questions about the study you can call @212-888-8516.